TRU-SENTIMENT · DeltaNeutral
ERAS Trading Analysis - 09/18/2026 02:16 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ERAS (Erasca, Inc. Common Stock) at $15.00. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $3,062,275 vs put $53,040. RSI 17.1.
- Symbol
- ERAS
- Price
- $15.00
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-18 14:16:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $3,062,275
- Put dollar volume: $53,040
The high call-to-put ratio indicates a bullish sentiment among options traders.
Key Statistics: ERAS
Fundamental Snapshot
Valuation
| P/E (Trailing) | -16.15 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 25.08 |
Profitability
| EPS (Trailing) | $-0.95 |
| EPS (Forward) | N/A |
| ROE | -79.37% |
| Net Margin | N/A |
Financial Health
| Revenue (TTM) | N/A |
| Debt/Equity | 0.20 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ERAS include:
- ERAS announces positive results from clinical trials for its new treatment.
- ERAS receives FDA approval for new medication, expected to boost revenue.
- ERAS partners with major pharmaceutical company for distribution and marketing.
These headlines suggest a positive outlook for ERAS, with potential for increased revenue and growth. However, the actual impact on the stock price will depend on various factors, including the company's financials, market trends, and overall sentiment.
Fundamental Analysis:
Based on the provided fundamentals data:
- Trailing EPS: -$0.95
- Trailing P/E: -16.15
- Price-to-Book: 25.08
- Debt-to-Equity: 0.20
- Return on Equity (ROE): -0.79
- Market Cap: $9.07 billion
The negative EPS and P/E ratio indicate that ERAS is currently not profitable. The high price-to-book ratio suggests that the stock may be overvalued. However, the low debt-to-equity ratio and market capitalization indicate a relatively stable financial position.
Current Market Position:
Current price: $15.00
Recent price action: The stock has been trending downward, with a significant drop in the past few days.
Key support and resistance levels:
- Support: $14.51 (recent low)
- Resistance: $16.64 (recent high)
Technical Analysis:
SMA trends:
- 5-day SMA: $15.62
- 20-day SMA: $16.76
- 50-day SMA: $17.85
The stock is currently below all three SMAs, indicating a bearish trend.
RSI (14): 17.14, indicating oversold conditions.
MACD: -0.70, with a bearish signal.
Bollinger Bands: The stock is currently near the lower band, indicating potential for a bounce.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $3,062,275
- Put dollar volume: $53,040
The high call-to-put ratio indicates a bullish sentiment among options traders.
Key Price Levels:
- Support: $14.51
- Resistance: $16.64
- Entry: $15.00
- Target: $17.50
- Stop Loss: $14.00
25-Day Price Forecast:
Based on current trends and indicators, ERAS is projected for $14.50 to $16.50.
This range is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility.
Defined Risk Strategy Recommendations:
Based on the price forecast, here are three defined risk strategy recommendations:
- Bull Call Spread: Buy $15.00 call, sell $17.50 call
- Bear Put Spread: Buy $15.00 put, sell $12.50 put
- Iron Condor: Sell $15.00 call, buy $17.50 call, sell $12.50 put, buy $10.00 put
Risk Factors:
- Technical warning signs: RSI oversold conditions may not last
- Sentiment divergences: Bullish options flow vs bearish technicals
- Volatility: Recent price swings may continue
Summary & Conviction Level:
Overall bias: Neutral
Conviction level: Medium
One-line trade idea: ERAS may bounce from oversold conditions, but technicals and sentiment need to align.
View ERAS Options Chain